Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1534

1.

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report.

Narita Z, Takano H, Sumiyoshi T.

Neuropsychiatr Dis Treat. 2017 Mar 13;13:775-777. doi: 10.2147/NDT.S132516. eCollection 2017 Mar 13.

PMID:
28331329
2.

Etiological profile of noncompressive myelopathies in a tertiary care hospital of Northeast India.

Kayal AK, Goswami M, Das M, Basumatary LJ, Bhowmick SS, Synmon B.

Ann Indian Acad Neurol. 2017 Jan-Mar;20(1):41-50. doi: 10.4103/0972-2327.199904.

3.

Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Choy BN, Ng AL, Lai JS.

Int Ophthalmol. 2017 Mar 13. doi: 10.1007/s10792-017-0491-9. [Epub ahead of print]

PMID:
28289949
4.

Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder.

Masuda H, Mori M, Uchida T, Uzawa A, Ohtani R, Kuwabara S.

J Neuroimmunol. 2017 Apr 15;305:102-107. doi: 10.1016/j.jneuroim.2017.01.024.

PMID:
28284329
5.

Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.

Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004.

PMID:
28283104
6.

Headache in Neuromyelitis Optica.

Masters-Israilov A, Robbins MS.

Curr Pain Headache Rep. 2017 Apr;21(4):20. doi: 10.1007/s11916-017-0620-1. Review.

PMID:
28281110
7.

The role of aquaporin-4 in synaptic plasticity, memory and disease.

Hubbard JA, Szu JI, Binder DK.

Brain Res Bull. 2017 Mar 6. pii: S0361-9230(17)30115-6. doi: 10.1016/j.brainresbull.2017.02.011. [Epub ahead of print] Review.

PMID:
28274814
8.

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.

Kim Y, Kim G, Kong BS, Lee JE, Oh YM, Hyun JW, Kim SH, Joung A, Kim BJ, Choi K, Kim HJ.

J Clin Neurol. 2017 Mar 6. [Epub ahead of print]

9.

Lesions of the posterior limb of the internal capsule in neuromyelitis optica spectrum disorder.

Long Y, Wu L, Zhong R, Ouyang X, Liang J, Gao C, Chen X, Qiu W, Chang Y, Wang Z, Ye J.

Neurol Res. 2017 Mar 6:1-5. doi: 10.1080/01616412.2017.1298230. [Epub ahead of print]

PMID:
28262035
10.

Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?

Reindl M, Jarius S, Rostasy K, Berger T.

Curr Opin Neurol. 2017 Feb 28. doi: 10.1097/WCO.0000000000000446. [Epub ahead of print]

PMID:
28248700
11.

Relapsing Polychondritis Presented with Encephalitis Followed by Brain Atrophy.

Ahn SW, Park MS, Jeong HB, Kwon OS, Yoon BN, Kim HS, Choi ST.

Exp Neurobiol. 2017 Feb;26(1):66-69. doi: 10.5607/en.2017.26.1.66.

12.

Initial Pattern of Optic Nerve Enhancement in Korean Patients with Unilateral Optic Neuritis.

Son DY, Park KA, Seok SS, Lee JY, Oh SY.

Korean J Ophthalmol. 2017 Feb;31(1):71-79. doi: 10.3341/kjo.2017.31.1.71.

13.

[Neuromyelitis optica].

Pache F, Wildemann B, Paul F, Jarius S.

Fortschr Neurol Psychiatr. 2017 Feb;85(2):100-114. doi: 10.1055/s-0042-124186. German.

PMID:
28235212
14.

The gut microbiome in human neurological disease: A review.

Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E.

Ann Neurol. 2017 Feb 21. doi: 10.1002/ana.24901. [Epub ahead of print] Review.

PMID:
28220542
15.

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report.

Hodecker SC, Stellmann JP, Rosenkranz SC, Young K, Holst B, Friese MA, Heesen C.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e328. doi: 10.1212/NXI.0000000000000328. No abstract available.

16.

Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis.

Matsumoto Y, Mori S, Ueda K, Kurimoto T, Kanamori A, Yamada Y, Nakashima I, Nakamura M.

PLoS One. 2017 Feb 15;12(2):e0171880. doi: 10.1371/journal.pone.0171880.

17.

Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN.

Indian J Hematol Blood Transfus. 2017 Mar;33(1):97-105. doi: 10.1007/s12288-016-0661-3.

PMID:
28194064
18.

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.

Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF.

Acta Neuropathol. 2017 Apr;133(4):597-612. doi: 10.1007/s00401-017-1682-1.

PMID:
28184993
19.

Upregulation of Bcl-2 and Its Promoter Signals in CD4+ T Cells during Neuromyelitis Optica Remission.

Yang T, Wang S, Yang X, Zheng Q, Wang L, Li Q, Wei M, Du Z, Fan Y.

Front Neurosci. 2017 Jan 24;11:11. doi: 10.3389/fnins.2017.00011.

20.

Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.

Duan Y, Liu Z, Liu Y, Huang J, Ren Z, Sun Z, Chen H, Dong H, Ye J, Li K.

Acta Radiol. 2017 Jan 1:284185116683575. doi: 10.1177/0284185116683575. [Epub ahead of print]

PMID:
28173728

Supplemental Content

Loading ...
Support Center